speb/financial-data huggingface dataset:
EMR.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 248317.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 248317.00
EMR.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 260000.00
EMR.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -37177.00
EMR.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -46362.00
EMR.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 3760.00
EMR.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 153381.00
EMR.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 110779.00
EMR.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 50082.00
EMR.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 230783.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1017287.00
EMR.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2990.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 333703.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 21981.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 21981.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1505372.00
EMR.V cash_flow (quarterly, 2025-09-30) — Depreciation: 2990.00
EMR.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2990.00
EMR.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2990.00
EMR.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
EMR.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 397325.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 713971.00
EMR.V income_statement (quarterly, 2025-09-30) — EBIT: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — EBITDA: 400315.00
EMR.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 248317.00
EMR.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -50598.00
EMR.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 170.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -37835.00
EMR.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 103596.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2319039.00
EMR.V income_statement (quarterly, 2025-09-30) — Gross Profit: -2990.00
EMR.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 3605.00
EMR.V income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
EMR.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1039268.00
EMR.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 260000.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 52029.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 397325.00
EMR.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 397325.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -773.00
EMR.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -773.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 2188956.00
EMR.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 295000.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1017287.00
EMR.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -200755.00
EMR.V income_statement (quarterly, 2025-09-30) — Normalized Income: -113584.50
EMR.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -50598.00
EMR.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -548871.00
EMR.V income_statement (quarterly, 2025-09-30) — Operating Income: -202972.00
EMR.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Current Assets: -21.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 21981.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -37835.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 9667796.00
EMR.V income_statement (quarterly, 2025-09-30) — Other Gand A: 96546.00
EMR.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 601070.00
EMR.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 96386.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 2224027.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 10000.00
EMR.V income_statement (quarterly, 2025-09-30) — Other Special Charges: -600900.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Payables: 1483391.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1483391.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 14407.00
EMR.V income_statement (quarterly, 2025-09-30) — Pretax Income: 397325.00
EMR.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Receivables: 71000.00
EMR.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2990.00
EMR.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2990.00
EMR.V income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 3445.00
EMR.V income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 3445.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -57631903.00
EMR.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 0.00
EMR.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 103596.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 51771157.00
EMR.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 600900.00
EMR.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1017287.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1017287.00
EMR.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 90160.50
EMR.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
EMR.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 61000.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 2522659.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1017287.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 21981.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1017287.00
EMR.V income_statement (quarterly, 2025-09-30) — Total Expenses: 202972.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1505372.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2188956.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 773.00
EMR.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 601070.00
EMR.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 601070.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -1171669.00
EMR.V income_statement (annual, 2025-12-31) — +Operating Expense: 633976.00
EMR.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 156857.00
EMR.V income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
EMR.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
EMR.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 645705.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 645705.00
EMR.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -130097.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -130097.00
EMR.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
EMR.V income_statement (annual, 2025-12-31) — Basic Average Shares: 51771157.00
EMR.V income_statement (annual, 2025-12-31) — Basic EPS: 0.01
EMR.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 52366.00
EMR.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 248317.00
EMR.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -175000.00
EMR.V balance_sheet (annual, 2025-12-31) — Capital Stock: 49250269.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 49250269.00
EMR.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 245048.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 245048.00
EMR.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 587963.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 587963.00
EMR.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 513883.00
EMR.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 492502.00
EMR.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 170000.00
EMR.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -125000.00
EMR.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -496695.00
EMR.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -389686.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Account Payable: 60844.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Payable: 60844.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 60844.00
EMR.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -3247.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 6192.00
EMR.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -14307.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Receivables: 65677.00
EMR.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -193465.00
EMR.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 132713.00
EMR.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -211019.00
EMR.V cash_flow (annual, 2025-12-31) — Changes In Cash: 187188.00
EMR.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -8763.00
EMR.V balance_sheet (annual, 2025-12-31) — Common Stock: 49250269.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 49250269.00
EMR.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1386967.00
EMR.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
EMR.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 6004.00
EMR.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 14.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 72818.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 72818.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Assets: 659023.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 659023.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Debt: 723411.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 723411.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 723411.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 723411.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 1523729.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1523729.00
EMR.V balance_sheet (annual, 2025-12-31) — Current Notes Payable: 723411.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 723411.00
EMR.V cash_flow (annual, 2025-12-31) — Depreciation: 6004.00
EMR.V cash_flow (quarterly, 2025-12-31) — Depreciation: 14.00
EMR.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 6004.00
EMR.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 14.00
EMR.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 6004.00
EMR.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 14.00
EMR.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 72715944.00
EMR.V income_statement (annual, 2025-12-31) — Diluted EPS: 0.00
EMR.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 158805.00
EMR.V balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 81795.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 81795.00
EMR.V income_statement (annual, 2025-12-31) — EBIT: 348174.00
EMR.V income_statement (quarterly, 2025-12-31) — EBIT: 231447.00
EMR.V income_statement (annual, 2025-12-31) — EBITDA: 354178.00
EMR.V income_statement (quarterly, 2025-12-31) — EBITDA: 231461.00
EMR.V cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5494.00
EMR.V cash_flow (annual, 2025-12-31) — End Cash Position: 245048.00
EMR.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 245048.00
EMR.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 513883.00
EMR.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 492502.00
EMR.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -671695.00
EMR.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -551265.00
EMR.V income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 287068.00
EMR.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 105373.00
EMR.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 105090.00
EMR.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -58000.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -58000.00
EMR.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 403680.00
EMR.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 101925.00
EMR.V balance_sheet (annual, 2025-12-31) — Gross PPE: 2381770.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2381770.00
EMR.V income_statement (annual, 2025-12-31) — Gross Profit: -6004.00
EMR.V income_statement (quarterly, 2025-12-31) — Gross Profit: -14.00
EMR.V income_statement (annual, 2025-12-31) — Insurance And Claims: 18588.00
EMR.V income_statement (quarterly, 2025-12-31) — Insurance And Claims: 5496.00
EMR.V income_statement (annual, 2025-12-31) — Interest Expense: 72642.00
EMR.V income_statement (quarterly, 2025-12-31) — Interest Expense: 72642.00
EMR.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 72642.00
EMR.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 72642.00
EMR.V balance_sheet (annual, 2025-12-31) — Interest Payable: 72818.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Interest Payable: 72818.00
EMR.V balance_sheet (annual, 2025-12-31) — Invested Capital: 2110378.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2110378.00
EMR.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: 170000.00
EMR.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -125000.00
EMR.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
EMR.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 282843.00
EMR.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 261462.00
EMR.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 282843.00
EMR.V balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
EMR.V balance_sheet (annual, 2025-12-31) — Net Debt: 478363.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 478363.00
EMR.V cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
EMR.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -26842.00
EMR.V income_statement (annual, 2025-12-31) — Net Income: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 158805.00
EMR.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 275532.00
EMR.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 158805.00
EMR.V income_statement (annual, 2025-12-31) — Net Interest Income: -73297.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -71950.00
EMR.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 282843.00
EMR.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 261462.00
EMR.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 282843.00
EMR.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -73297.00
EMR.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -71950.00
EMR.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 231040.00
EMR.V cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 345000.00
EMR.V balance_sheet (annual, 2025-12-31) — Net PPE: 2251673.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 2251673.00
EMR.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -175000.00
EMR.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -470000.00
EMR.V cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
EMR.V cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -21381.00
EMR.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1386967.00
EMR.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -634631.00
EMR.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -156165.00
EMR.V income_statement (annual, 2025-12-31) — Normalized Income: -564955.65
EMR.V income_statement (quarterly, 2025-12-31) — Normalized Income: -170677.10
EMR.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -496695.00
EMR.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -376265.00
EMR.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -596368.00
EMR.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -22310.00
EMR.V income_statement (annual, 2025-12-31) — Operating Income: -639980.00
EMR.V income_statement (quarterly, 2025-12-31) — Operating Income: -156871.00
EMR.V income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
EMR.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
EMR.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Current Assets: 346.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 346.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -58000.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -58000.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 9667796.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 9667796.00
EMR.V income_statement (annual, 2025-12-31) — Other Gand A: 381065.00
EMR.V income_statement (quarterly, 2025-12-31) — Other Gand A: 104402.00
EMR.V income_statement (annual, 2025-12-31) — Other Income Expense: 988809.00
EMR.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 387626.00
EMR.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: -214426.00
EMR.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -201605.00
EMR.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 230296.00
EMR.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 54932.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Properties: 2286758.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 2286758.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Receivables: 2000.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 2000.00
EMR.V balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 342915.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 342915.00
EMR.V income_statement (annual, 2025-12-31) — Other Special Charges: -596368.00
EMR.V income_statement (quarterly, 2025-12-31) — Other Special Charges: 4532.00
EMR.V income_statement (annual, 2025-12-31) — Other Taxes: 0.00
EMR.V balance_sheet (annual, 2025-12-31) — Payables: 727500.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Payables: 727500.00
EMR.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 800318.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 800318.00
EMR.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 28714.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 28714.00
EMR.V income_statement (annual, 2025-12-31) — Pretax Income: 275532.00
EMR.V income_statement (quarterly, 2025-12-31) — Pretax Income: 158805.00
EMR.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -175000.00
EMR.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -175000.00
EMR.V balance_sheet (annual, 2025-12-31) — Receivables: 42000.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Receivables: 42000.00
EMR.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 6004.00
EMR.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 14.00
EMR.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 6004.00
EMR.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 14.00
EMR.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 4027.00
EMR.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: -7973.00
EMR.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 4027.00
EMR.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: -7973.00
EMR.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -57473098.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -57473098.00
EMR.V income_statement (annual, 2025-12-31) — Salaries And Wages: 0.00
EMR.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 0.00
EMR.V income_statement (annual, 2025-12-31) — Selling General And Administration: 403680.00
EMR.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 101925.00
EMR.V balance_sheet (annual, 2025-12-31) — Share Issued: 51771157.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 51771157.00
EMR.V income_statement (annual, 2025-12-31) — Special Income Charges: 883436.00
EMR.V income_statement (quarterly, 2025-12-31) — Special Income Charges: 282536.00
EMR.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
EMR.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
EMR.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1386967.00
EMR.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1386967.00
EMR.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 148321.35
EMR.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 58143.90
EMR.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
EMR.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
EMR.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 40000.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 40000.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Assets: 2910696.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 2910696.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1386967.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Debt: 723411.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 723411.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1386967.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1386967.00
EMR.V income_statement (annual, 2025-12-31) — Total Expenses: 639980.00
EMR.V income_statement (quarterly, 2025-12-31) — Total Expenses: 156871.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1523729.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1523729.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2251673.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2251673.00
EMR.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (annual, 2025-12-31) — Total Other Finance Cost: 655.00
EMR.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -692.00
EMR.V income_statement (annual, 2025-12-31) — Total Unusual Items: 988809.00
EMR.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 387626.00
EMR.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 988809.00
EMR.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 387626.00
EMR.V cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -100150.00
EMR.V balance_sheet (annual, 2025-12-31) — Working Capital: -864706.00
EMR.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -864706.00
EMR.V income_statement (annual, 2025-12-31) — Write Off: 0.00
EMR.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 236421.00
EMR.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 439931.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -136777.00
EMR.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 62636856.00
EMR.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
EMR.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 245048.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 49720270.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 266605.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 783142.00
EMR.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 407371.00
EMR.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -387556.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -205774.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Payable: -190095.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -190095.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -4296.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4807.00
EMR.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -199198.00
EMR.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: 19815.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 49720270.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1745091.00
EMR.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 399530.00
EMR.V cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -231040.00
EMR.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 6680.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 97474.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 863305.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Debt: 721730.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 721730.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1350489.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 721730.00
EMR.V cash_flow (quarterly, 2026-03-31) — Depreciation: 6680.00
EMR.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6680.00
EMR.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6680.00
EMR.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 62636856.00
EMR.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
EMR.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -80236.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 91354.00
EMR.V income_statement (quarterly, 2026-03-31) — EBIT: -61550.00
EMR.V income_statement (quarterly, 2026-03-31) — EBITDA: -54870.00
EMR.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1742.00
EMR.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 266605.00
EMR.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 407371.00
EMR.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -387556.00
EMR.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 181244.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -74767.00
EMR.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 111009.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2369052.00
EMR.V income_statement (quarterly, 2026-03-31) — Gross Profit: -6680.00
EMR.V income_statement (quarterly, 2026-03-31) — Insurance And Claims: 388.00
EMR.V income_statement (quarterly, 2026-03-31) — Interest Expense: 18686.00
EMR.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 18686.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Interest Payable: 97474.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2466821.00
EMR.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 399530.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 168490.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 455125.00
EMR.V cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 1038.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -80236.00
EMR.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -80236.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -18863.00
EMR.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -18863.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 2232275.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1745091.00
EMR.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -236114.00
EMR.V income_statement (quarterly, 2026-03-31) — Normalized Income: -261480.00
EMR.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -387556.00
EMR.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1038.00
EMR.V income_statement (quarterly, 2026-03-31) — Operating Income: -243101.00
EMR.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 66067827.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 153.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -74767.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 9652922.00
EMR.V income_statement (quarterly, 2026-03-31) — Other Gand A: 62865.00
EMR.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 181728.00
EMR.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 18686.00
EMR.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 484.00
EMR.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 23121.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Properties: 2274040.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Receivables: 5000.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 516537.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Payables: 531285.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 628759.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 33010.00
EMR.V income_statement (quarterly, 2026-03-31) — Pretax Income: -80236.00
EMR.V cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 238881.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Receivables: 47000.00
EMR.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 6680.00
EMR.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6680.00
EMR.V cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -231040.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -57553334.00
EMR.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 47756.00
EMR.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 102291.00
EMR.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 213300.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 66067827.00
EMR.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 47756.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1745091.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1745091.00
EMR.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 42000.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 3095580.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1745091.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 721730.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1745091.00
EMR.V income_statement (quarterly, 2026-03-31) — Total Expenses: 243101.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1350489.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2232275.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 177.00
EMR.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: 181244.00
EMR.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 181244.00
EMR.V cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -182282.00
EMR.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -487184.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — +Operating Expense: 205607000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — +Total Revenue: 3598500000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 430134000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1578227000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -153619000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 7500000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Amortization: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 5096000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 55530807.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Basic EPS: 14.21
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 504309000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 39135000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -142792000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 629000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 117500000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 610529000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 899235000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 249979000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 360550000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -186992000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -314973000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 510614000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Payable: 27108000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -645368000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -870058000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 106220000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Common Stock: 117500000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 3801799000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 3032000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 2292980000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Assets: 4147585000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 629000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Debt: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 629000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 39221000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 1085533000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Depreciation: 21512000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 21512000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 25206000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 25206000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 55530807.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Diluted EPS: 14.21
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 789283000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — EBIT: 1075173000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — EBITDA: 1100379000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — End Cash Position: 610529000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 27640000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 541285000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 83579000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 703000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -15000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 24063000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Goodwill: 58969000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 58976000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 526307000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Gross Profit: 1305520000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Interest Expense: 243000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 243000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Interest Income: 31939000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 31939000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -243000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Inventory: 541285000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 3838930000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -147791000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 76806000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 5096000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 218470000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 37131000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 37131000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 265670000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 9427000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income: 789283000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 789283000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 789283000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 789283000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 789283000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 1074930000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 789283000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -58248000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Interest Income: -25520000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: -8254000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -703000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 5502000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 5502000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -25520000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 22381000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 2000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Net PPE: 372688000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -80588000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 3742823000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 4516000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2722000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 847000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 1100364000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Normalized Income: 789271986.03
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 226371000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Operating Income: 1099913000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Operating Revenue: 3598500000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 55530807.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 64449000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 508153000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: -1000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 7000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 243000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -5000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 29999000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 522000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 46213000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Payable: 97547000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 813298000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 288706000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Other Special Charges: -15000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Payables: 527681000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 872000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 186000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 232991000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Pretax Income: 1074930000.00
EMSLIMITED.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -58248000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -703000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment Properties: -8254000.00
EMSLIMITED.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -84544000.00
EMSLIMITED.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 2292980000.00